Business
Vaccine ‘not a panacea’ as surgeries bounce back: Cochlear boss – Sydney Morning Herald
The hearing implant maker is still on the long path back to a COVID normal but can see some light at the end of the tunnel.
When asked exactly how long it will be before all markets had recovered to the same or better levels than before the pandemic, Mr Howitt said it was more likely to be years than months. I think the thing is that the bigger markets where we are in have bounced back quickly, so that is what gives us some confidence. But I think the tail could be quite long.
Cochlears sales in emerging regions, including Latin America and Brazil, were down 30 per cent for the first half (year-on-year), while sales…
-
General16 hours agoMore buses without dedicated lanes likely after Gold Coast light rail plan scrapped
-
Business22 hours agoBuy this monthly high-yield ETF instead
-
Noosa News15 hours agoBrisbane kindergarten thrown into chaos amid bitter dispute
-
Noosa News17 hours agoCrocodile Hunter’s father calls for influencer’s deportation over wildlife stunts